Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $48.9700 (0.33%) ($48.9700 - $49.0300) on Wed. Feb. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 25 | Latest Price | $48.9700(0.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO declines -2.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(42%) XBI(42%) IFRA(40%) IWO(37%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.035% in a week (0% probabilities). VXX(-16%) VIXM(-13%) UUP(-11%) GLD(-10%) BND(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $44.71(-8.7%) | Resistance Level | $51.02 | 5 Day Moving Average | $49.06(-0.18%) | 10 Day Moving Average | $50.33(-2.7%) | 20 Day Moving Average | $51.02(-4.02%) | To recent high | -17.5% | To recent low | 0.3% | Market Cap | $6.693b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |